EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata

Efsun Tanacan, Aynure Oztekin, Unsal Savcı, Engin Senel, Coskun Oztekin, Salim Neselioglu, Ozcan Erel

Dermatology Practical & Conceptual · 31.01.2023 · e2023017

DOI: 10.5826/dpc.1301a17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology Practical & Conceptual, online erschienen am 31.01.2023. Verfasst von Efsun Tanacan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Ufuk University Hospital, Ankara, Turkey. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate the role of ischemia-modified albumin (IMA) and IMA/albumin levels in patients with AA.

Methods

The present prospective crossectional study includes patients ≥ 18 who admitted to the Dermatology and Venerology Department of XXXX University Hospital between April 1 2021, and September 30 2021. 70 patients participated in the study (n=34 for the study group and n=36 for the control group). Demographic features, clinical characteristics, IMA, and IMA/albumin levels were compared between the groups. Study group was divided into subgroups based on the number of patches, disease duration, and number of disease attacks. IMA and IMA/albumin levels were compared between each subgroup.

Results

Study and control groups were similar with regard to demographic features and clinical characteristics. Significant differences were observed between the mean IMA and IMA /albumin ratio (p=0.004 and 0.012, respectively). The study subgroups were comparable for the number of patches, disease duration and number of disease attack.

Conclusion

Although oxydative stress is an important component in the etiology of AA, IMA and IMA/albumin may not be useful in the prediction of disease severity in patients with AA. Keywords: Alopecia areata, ischemia-modified albumin, IMA/albumin, disease severity.

Autor:innen und Institutionen

  • Department of Dermatology and Venerology, Ufuk University Hospital, Ankara, Turkey.
  • Department of Dermatology and Venerology, Hitit University Faculty of Medicine Çorum, Turkey.
  • Department of Microbiology, Hitit University Faculty of Medicine, Çorum, Turkey.
  • Department of Family Medicine, Hitit University Faculty of Medicine, Çorum, Turkey.
  • Department of Clinical Biochemistry, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.

Zitieren

APA

Tanacan, E., Oztekin, A., Savcı, U., Senel, E., Oztekin, C., Neselioglu, S., & Erel, O. (2023). The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata. Dermatology Practical & Conceptual, e2023017. https://doi.org/10.5826/dpc.1301a17

Vancouver

Tanacan E, Oztekin A, Savcı U, Senel E, Oztekin C, Neselioglu S, et al. The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata. Dermatology Practical & Conceptual. 2023:e2023017. doi:10.5826/dpc.1301a17

BibTeX
@article{Tanacan2023,
  author = {Tanacan, Efsun and Oztekin, Aynure and Savcı, Unsal and Senel, Engin and Oztekin, Coskun and Neselioglu, Salim and Erel, Ozcan},
  title = {The Role of Ischemia-modified Albumin and Ischemia-modified Albumin to Albumin Ratios in Patients with Alopecia Areata},
  journal = {Dermatology Practical & Conceptual},
  year = {2023},
  pages = {e2023017},
  doi = {10.5826/dpc.1301a17}
}
Kostenlos starten →